Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge  by Silbiger, Sharon et al.
Kidney International, Vol. 43 (1993), pp. 853—864
Nonenzymatic glycation of mesangial matrix and prolonged
exposure of mesangial matrix to elevated glucose reduces
collagen synthesis and proteoglycan charge
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Nonenzymatic glycation of mesangial matrix and prolonged exposure of
mesangial matrix to elevated glucose reduces collagen synthesis and
proteoglycan charge. Expansion of the mesangial matrix in diabetes
occurs after prolonged exposure to the diabetic milieu. To mimic the
long-term hyperglycemia of diabetes mellitus we developed tissue
culture systems that might approximate the chronic state. This was
accomplished in two ways: (1) by growing mesangial cells on extracel-
lular matrix glycated and crosslinked in vitro and (2) by continuously
growing cells on their own matrix on filters in elevated glucose medium
(500 mgldl) for up to eight weeks without passage. Synthesis of collagen
and proteoglycans was evaluated in cells grown under these conditions.
In both these situations, 3H-proline incorporation into collagenase
sensitive protein and 35S incorporation into sulfated proteins were
reduced compared to control cultures. Despite reduction in 35S incor-
poration into proteoglycans in the high glucose cultures, total gly-
cosaminoglycan content was unchanged. However, proteoglycans gen-
erated by mesangial cells grown in elevated glucose media were of a
lower negative charge than controls. In mesangial cells continuously
grown on filters, the levels of messenger RNA for collagen types I and
IV, biglycan and TGF-fl were not different in cells grown at elevated or
standard glucose concentrations for two and four weeks. We conclude
that crosslinking of mesangial matrix or continuous culture of cells for
prolonged periods of time in high glucose medium, which may also
crosslink matrix, suppresses collagen synthesis and reduces the nega-
tive charges on matrix proteoglycans without altering mRNA levels.
Diabetic nephropathy affects approximately 40% of patients
with diabetes mellitus (DM) [11. Histopathologically, both the
glomerular basement membrane (GBM) and the mesangial
matrix (MM) are increased in area [21, and this expansion is felt
to be a major contributor to diabetic renal failure. Both the
GBM and MM are composed of various matrix components. In
the GBM, type IV collagen, laminin and heparan sulfate pro-
teoglycans (HSPG) predominate while the MM contains types
IV and V collagen, laminin, fibronectin, thrombospondin, and
primarily chondroitinldermatan sulfate proteoglycans (CS!
DSPG) with small amounts of HSPG [1]. The predominant
mesangial matrix abnormality found in both human and rat
diabetes mellitus is an increase in type IV collagen [3—61.
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Furthermore, nonenzymatic glycation and crosslinking of both
GBM and MM proteins are found in DM and are thought to
contribute to diabetic glomerulosclerosis [7].
Changes in the quantity or character of matrix proteins have
the potential for markedly altering the structure and character-
istics of matrix. For example, nonenzymatic glycation of lami-
nm, as seen in long-term diabetes mellitus, impairs self assem-
bly [8] and that of fibronectin interferes with its ability to bind
other matrix components [9]. Glycation of collagen promotes
trapping of low density lipoproteins and other nonlipid proteins
[10]. Glycation and crosslinking of long-lived matrix proteins
also impairs their degradation [11]. Furthermore, glycation of
matrix may influence the interaction of growth factors with
matrix and cells.
The GBM and MM expansion in diabetes may be due both to
increased generation of matrix proteins secondary to the dia-
betic milieu as well as decreased degradation of matrix proteins
secondary to structural changes induced by DM. Mesangial cell
culture has been used as a model to study the effects of glucose
and cytokines on the generation of matrix proteins. Recently,
Ayo and coworkers reported that rat mesangial cells (MC)
grown in 30 m glucose medium for one week accumulate more
fibronectin, laminin and type IV collagen than MC grown in 10
m glucose. These increases were accompanied by an increase
in synthetic rate and an increase in mRNA for all three matrix
components [12]. Comparable results have been reported for
cultured mouse kidney cells [13]. Our laboratory has studied the
effect of elevated glucose concentrations on the generation of
proteoglycans by rat MC over a one week period. Elevated
glucose did not change the total amount of glycosaminoglycans
produced nor the steady state level of mRNA for the proteo-
glycan biglycan [14]. Of interest, we found a significant reduc-
tion in the negative charge density of the proteoglycans gener-
ated in elevated glucose medium (30 mM) compared to those
generated in standard glucose medium (10 mM).
The aforementioned studies indicate that exposure of cul-
tured mesangial cells to high glucose concentrations over a one
week period leads to increases in type IV collagen, fibronectin
and laminin, and structural changes in proteoglycans. How-
ever, these short-term culture conditions may not adequately
simulate in vivo human diabetes where years of exposure to the
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elevated levels of glucose is required before significant alter-
ations in glomerular matrix occur. Of interest, persistent in-
creased synthesis of matrix proteins may not occur in long term
diabetes. In fact several investigators have found reduced
synthesis of collagen in diabetic rats as well as reduction in the
mRNA of type IV collagen [15] as early as two weeks after the
onset of diabetes. Falk and colleagues, using immunohistologic
techniques found increases in types IV and V collagen, laminin
and fibronectin in the mesangium and glomerular basement
membranes in early, moderate diabetic nephropathy (urinary
protein <300 mg/dl; normal creatinine clearances) but signifi-
cant reductions in these components in the more advanced
stages of nephropathy (heavy proteinuria; abnormal serum
creatinines) [16]. To further evaluate the effect of chronic
diabetes on mesangial matrix production we have recently
developed a tissue culture system whereby matrix is first
generated by mesangial cells and after removal of cells, gly-
cated and crosslinked in vitro, a system designed to resemble
matrix alterations after long-term in vivo diabetes. Using this
system we reported that crosslinked matrix, as would occur in
advanced glycation of diabetes, affects mesangial cell behavior
by decreasing proliferation [17]. We now use this model of in
vitro advanced glycation of matrix to examine subsequent
matrix generation by mesangial cells plated on the modified
matrix. In addition, we developed a complementary model of
chronic hyperglycemia by continuous culturing of mesangial
cells long-term on filters in high glucose medium without
passaging of the cells.
Using these tissue culture systems we evaluated both colla-
gen and proteoglycan synthesis. In contrast to the findings in
short-term cultures, collagen synthesis by cells grown on
crosslinked matrix and by cells grown long term in elevated
glucose medium was suppressed compared to cells grown on
control matrix or at control glucose concentrations. Incorpora-
tion of [35S] into proteoglycans was also decreased by MC
plated on glycated matrix or maintained for four weeks in
elevated glucose medium, resulting in proteoglycans of lower
negative charge. Taken together, these results indicate that
enhanced synthesis of matrix may not be the only factor
contributing to the matrix expansion observed in long-term
diabetes.
Methods
Rat mesangial cell culture
Mesangial cells were cultured by standard techniques using
glomerular isolation by differential sieving [18]. Essentially,
Sprague-Dawley rats, 75 to 100 g (Charles River, Wilmington,
Massachusetts, USA) were anesthetized and bilateral nephrec-
tomies performed. The cortical tissue was minced and passed
sequentially through sieves of 250 xm, 150 sm and 75 xm
(Newark Wire Co.). The sieved material was then exposed to
collagenase (Calbiochem) and collected onto a 38 m sieve.
This suspension of >90% decapsulated glomeruli was sus-
pended in RPM! 1640 medium containing glutamine (Gibco),
20% fetal calf serum (FCS) and 1% penicillin-streptomycin
solution (Sigma). At confluence, cells were passaged by short
exposure to trypsin-EDTA (0.05% trypsin, 0.53 mM EDTA;
Gibco Laboratories, Grand Island, New York, USA), and
maintained in RPMI medium supplemented with 10% FCS.
Mesangial cells were used between the third and ninth pas-
sages.
Glycation and crosslinking of mesangial matrix
Mesangial cells were grown for two weeks in 6 or 12 well
plates with media changed biweekly. The cells were then
removed from the underlying matrix by a 15 minute exposure to
2.5 mrvt NH4OH and 0.1% triton x-100. The remaining matrix
was washed three times with phosphate buffered saline (PBS)
and distilled H2O [19]. Matrix was then glycated using either
200 m glucose-6-phosphate (G6P) for two weeks [20, 21] or 50
mM glycolaldehyde (GA) for 24 hours [22]. Crosslinking was
inhibited by the addition of equimolar aminoguanidine (AG) to
certain wells [22]. All solutions were made up in 0.2 M NaHPO4
(pH 7.8) and NaHPO4 alone was used for treatment of control
matrices.
At the end of the incubation period (24 hrs or 2 weeks), the
glycating solutions were removed and the matrix incubated with
1 M glycine ethyl ester (pH 8) for one hour in order to substitute
any remaining free carbonyl groups. The matrices were washed
with PBS and distilled H20. Tissue culture plates were then
sterilized by irradiation (10,000 rads) and stored at 4°C until use.
We have previously reported analysis of these matrix com-
ponents by indirect immunofluorescence, and Northern blot
analysis [17]. Glycation and crosslinking of the matrix was
evaluated by determining fluorophores using 370 nm excitation
and 440 nm emission wavelengths, as reported earlier [17].
Aminoguanidine prevented the increase in fluorophores seen in
matrices treated with G6P or GA [17].
Cell growth on filters
Mesangial cells, passages 3 to 9, were plated in tissue culture
wells containing Millipore GS filters (0.2 p) in standard RPMI
medium containing glutamine and 10% FCS. At 48 hours,
medium was changed to either RPM! medium containing 8% Nu
serum (Collaborative Research, Lexington, Massachusetts,
USA) and glucose at a concentration of 200 mg% (considered
the upper limit of normal in rats) or the same medium supple-
mented with glucose for a final concentration of 500 mg%.
Medium was changed biweekly, and cells were grown for 1, 2,
4 or 8 weeks on the filters. This system allows for slow
continual growth of mesangial cells without their peeling off
from the tissue culture dish at confluence, as seen when cells
are grown in standard plastic tissue culture wells.
Light and scanning electron micrographs were taken of filters
themselves, of mesangial cells grown on these filters, and of the
matrix generated by mesangial cells and adherent to the filters
after cells were removed by short exposure to 2.5 mM NH4OH/
0.1% triton x-100 [17, 19].
For the scanning electron micrographs, the samples were
postfixed with 1% osmium tetraoxide followed by dehydration
with progressive concentrations of ethanol. The samples were
passed through critical-point dehydration and gold coated.
Photographs were taken on a JEOL JSM 25S scanning electron
microscope (JEOL, Tokyo, Japan) at various magnifications
[17].
Evaluation of protein synthesis
Total protein and DNA. Both total protein and cellular DNA
were evaluated in cells cultured on filters for 1, 2, 4 or 8 weeks.
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For total protein evaluation, cells and matrix were solubilized
with I N NaOH and the Biorad assay performed using bovine
serum albumin as standard.
Cellular DNA was determined by a procedure modified from
West, Sattar and Kumar [23]. Essentially, the culture medium
was removed and the mesangial cells solubilized in a buffer
containing 10 mrvi EDTA at pH 12.3 for 20 minutes (37°C). The
pH was then reduced to 7.0 with the addition of 1 M KH2PO4.
The solubilized samples were transferred from the tissue cul-
ture wells to fluorimeter tubes and bisbenzimide (200 ng/ml) was
added. After vortexing, the samples were read on a fluores-
cence spectrophotometer, excitation wavelength 350 nm and
emission wavelength 455 nm and compared to a standard curve
of calf thymus DNA.
Serine incorporation into protein. Mesangial cells were
grown on 0.2 j.t filters as described earlier, in either standard
glucose (200 mg%) or elevated glucose (500 mg%) for four
weeks. They were then metabolically labeled with [3H]serine
(20 jiCi/ml) for 24 hours. At the end of the labeling period, the
medium was removed and the medium proteins precipitated
with TCA (20%, 4°C). The cell layers were washed extensively
and then scraped off of the underlying filters into buffer con-
sisting of PBS, EDTA and protease inhibitors. This cell suspen-
sion was polytroned for 15 seconds and the proteins precipi-
tated with TCA (20%) overnight. Both the medium and cell
fractions (TCA-precipitated) were centrifuged to achieve a tight
pellet (4000 RPM x 15 mm). The supernatants were discarded
and the pellets briefly resuspended in TCA (5%) and poured
over a glass filter attached to a vacuum apparatus. After
extensive washing with 5% TCA, the filters and trapped pro-
teins were used for liquid scintillation counting. Values repre-
sent [3H] serine incorporation into precipitated protein over the
24-hour labeling period.
Evaluation of matrix synthesis
Collagen. Collagenase-sensitive protein was evaluated in
cells grown on modified matrices (glycated-crosslinked) over a
24 hour period or on filters for 2, 4, or 8 weeks in standard
glucose (200 mg%) or elevated glucose (500 mg%) medium. In
the matrix experiments, rat mesangial cells (MC) (6 x i0
cells/mI) were plated onto the various matrices in proline-
deficient DMEM medium containing ascorbic acid (50 jig/ml),
[3H] proline (15 jiCi/mi), and beta-aminopropionitrile (f3-APN),
a cross-link inhibitor (80 jig/mI). We have previously reported
that cell attachment by four hours is the same for mesangial
cells plated on glycated and non-glycated matrices [17]. After a
24 hour incubation, the medium containing non-crosslinked
collagen was removed, centrifuged (2000 RPM x 10 mm) to
remove cellular elements, and the supernatant medium proteins
precipitated with 5 volumes of ETOH containing 3% BSA (4°C
overnight). The samples were centrifuged, the pellet washed
twice with ethanol, and then resuspended in 50 mrvi Tris buffer
containing CaCI2 (1 mM) and N-ethylmaleimide (4 mM). The
samples were then digested with 20 units of collagenase (type
VII, Sigma Chemical Co., St. Louis, Missouri, USA; 90 mm,
37°C) and the solution reprecipitated with TCA. The collage-
nase-sensitive proteins were digested and therefore not precip-
itable with TCA. The supernatant, containing collagenase sen-
sitive proteins, was used for liquid scintillation counting. The
pellet (collagenase-insensitive proteins) was resuspended and
aliquots counted [24].
A similar protocol was used in the experiments where cells
were grown for 2, 4 or 8 weeks on filters in standard or elevated
glucose medium. Essentially after growth for 2, 4 or 8 weeks,
cells were labeled with [3H] proline (30 jiCi/mi) for 24 hours.
Collagenase sensitive and insensitive protein production were
determined as described above. To verify that the collagenase
treatment digested all [3H] proline labeled collagen, aliquots of
the ethanol precipitates were either incubated with or without
collagenase (as above) and the samples then precipitated with
TCA. The resulting pellets were then electrophoresed on a 7.5%
SDS-polyacrylamide gel [25], dried and submitted to fluorogra-
phy after soaking with EN3HANCE (NEN).
Further verification that the method of [3H] proline incorpo-
ration into collagenase-sensitive protein represented collagen
was provided by amino acid analysis. Mesangial cells were
plated onto conventional plastic culture dishes or onto culture
dishes coated with modified or unmodified matrices under the
conditions stated above. After 24 hours of incubation in DMEM
containing ascorbic acid (50 jig!ml), /3-APN (80 jig/mI), and [3H]
proline (30 jiCiIml), media were removed and added to equal
parts of PBS containing inhibitors of proteolysis (PMSF 0.002
M, NEN 0.001 M, pepstatin 1 jiglml, sodium azide 0.02%). The
samples were lyophiized and reconstituted in 2.5 ml of 0.1 M
pyridine acetate buffer (pH 5.0). Unincorporated [3H] proline
was removed by elution on a Sephadex G25M column using 0.1
M pyridine acetate buffer. The eluted protein peaks were
lyophilized and reconstituted in 50 mrvi Tris buffer pH 7.5,
containing 1 mivi CaC12 and 4 m NEN. Collagenase digestion
was then carried out with 20 U type VII collagenase at 37°C for
16 hours. The digested material was applied to a 1.5 x 20 cm
Biogel P-4 column and eluted with 0.1 M pyridine acetate buffer
and 3 ml fractions were collected. The second peak, represent-
ing the collagenase digested protein (fractions 8 to 12), was
lysophilized and then subjected to acid hydrolysis in 1 ml of 6 N
HCI under nitrogen vacuum at 105°C for 24 hours. After
hydrolysis, 62.5 nM GPA was added to each sample as an
internal standard, the samples were filtered through an 0.22 jim
Millipore filter, evaporated and analyzed on a Beckman amino
acid analyzer adapted with a split-stream device, to determine
hydroxyproline and proline content.
In other experiments, we evaluated the effect of ascorbic acid
on collagen production by mesangial cells grown in standard or
elevated glucose medium for four weeks. Cells were grown on
filters as described above and labeled with [3H] proline for 24
hours in the presence or absence of ascorbate (50 jig/rn!).
Aliquots (0.2 ml) of the media were then used for determination
of [3H] proline incorporation into collagenase sensitive material
as described above. In addition, immunoprecipitations for
collagen types I and IV were performed. Briefly, aliquots of the
collagen containing media were mixed with equal volumes of
RIPA buffer consisting of 50 m Tris (pH 7.5), 150 mivi NaCI,
0.1% SDS, 1% triton x-100, 0.5% deoxycholate and 1 mrt
PMSF. Normal rabbit or goat serum (5 jil) was added followed
by 125 jil of a 10% suspension of protein A-positive Staphylo-
coccus aureus (Boehringer Mannheim Biochem, Indianapolis,
Indiana, USA). This was incubated on a rocker for one hour at
4°C. Non-specifically bound material was removed by centrif-
ugation for 10 minutes at 5,000 RPM. Collagens in the remaining
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supernates were then incubated with either 5 d of either a
rabbit antiserum raised against bovine type IV collagen (gift of
Dr. Hynda Kleinman, NIH, Bethesda, Maryland, USA) or 5;il
of a goat antibody against human and bovine type I collagen (0.5
mg/ml; Southern Biotechnology Associates, Inc.). After one
hour 125 d of protein A suspension (as above) was added and
the immunoprecipitates recovered by centrifugation. The re-
sulting pellet was washed three times with cold RIPA buffer and
then resuspended in 25 jsl of Laemmle sample buffer by boiling
(2 mm) and run on a 7.5% SDS polyacrylamide gel.
Proteoglycans/glycosaminoglycans. Several methods were
used to evaluate intact proteoglycans and glycosaminoglycan
side chains. The amount of guanidine extractable protein after
35S labeling was evaluated in cells plated on glycated matrices
and in cells grown on filters in medium of varying glucose
concentrations for four weeks.
For the "matrix" experiments, MC were plated on the
modified matrices at a concentration of 60,000 cells/mi and
labeled with 35S-Na2SO4 (20 CiIml) for 24 hours. At the end of
this period, the labeling medium was removed and after exten-
sive washing of the cell layers with PBS, 35S-proteins were
extracted from the celllextracellular matrix by a 4 M guanidine
HC1 solution containing protease inhibitors (benzamidine, io-
doacetamide, PMSF) for 48 hours at 4°C. Aliquots of' this
guanidine extract were used for liquid scintillation counting.
For the experiments where MC were grown on filters for four
weeks, cell layers were labeled with 35S-Na2SO4 as in the
"modified matrix" experiments. The labeled medium proteins
were precipitated with TCA (20%) and the cell layer 35S-
proteins extracted with the 4 M guanidine HC1 solution, This
extracted solution was also precipitated with 20% TCA. All
samples were centrifuged (4000 RPM X 15 mm), the superna-
tant discarded, and the pellet resuspended in a small amount of
5% TCA and poured through a glass filter-vacuum apparatus.
The samples were washed thoroughly with 5% TCA and the
ifiters containing trapped precipitated proteins counted for S.
In other experiments, the extracted 35S-proteins were dialyzed
against 6 M urea and run on a DEAE sepharose anion exchange
column (50 cc vol; 0.15 to 1.15 M NaCI gradient).
Total glycosaminoglycan quantity in cell cultures grown for
four weeks on filters was evaluated by a modified carbazole
reaction for determination of total uronic acid [26].
Northern blot analysis of matrix components
Messenger RNA levels of collagen I, collagen IV, TGF-/3 and
the proteoglycan, biglycan were evaluated in cells grown on
filters for two or four weeks in various glucose concentrations.
Total RNA was extracted from cells [27] and samples of 10 pg
were then used for Northern blot analysis. After electrophore-
sis on a 1% agarose gel the RNA was transferred to nylon filters
[28]. Labeling of the cDNA probes specific for alpha 2 (I)
procollagen [29], collagen IV (alpha-i chain) [30], TGF-f31 [31],
the core protein of biglycan [32], GAPDH [33] and 18S riboso-
mal RNA was accomplished by random-prime transcription
using [32P]-dCTP [34]. Nylon filters were prehybridized (65°C, 1
to 3 hrs) in a solution containing 1 M NaCI and 1% SDS, and
then hybridized with the labeled cDNA probes for 16 hours.
After the filters were washed to high stringency [0.1 X SSPE
(150 m NaCl, 10 ma'i NaH2PO4, 1 m EDTA, pH 7.4)11%
SDS] autoradiography with intensifying screens (—70°C) was
Table 1. [3H] proline incorporation into collagenase-sensitive protein
generated by MC plated for 24 hour periods on control or modified
matrices
CPM/well
Control G6P AG G6P + AG
Collagenase 96,336 81,407 100,337 96,129
sensitive
P vs. control <0.01
N (12)
Control
(12)
GA
(12)
AG
(9)
GA + AG
Collagenase 98,662 56,043 91,990 92,073
sensitive
P vs. control <0.001
N 9) (12) (11) (12)
Mesangial matrix was generated and modified as reported in detail by
Crowley et al. Matrix was modified with either glucose-6-phosphate
(G6P), aminoguanidine (AG), glycolaldehyde (GA) or combinations
thereof. Equal numbers of rat MC were then plated on these matrices
and 24 hr [3H1 proline incorporation into collagenase-sensitive material
was determined. Results are means SEM of the number of experi-
ments indicated in parentheses.
performed. Hybridization of the specific mRNAs was quanti-
tated by laser densitometry. Hybridization for GAPDH and for
18S ribosomal RNA were used to normalize for any differences
in RNA loading.
Results
Experiments on glycated matrix
We have recently reported that nonenzymatic glycation and
crosslinking of matrix components, as occurs in diabetes, can
be mimicked by incubation of mesangial matrix with glucose 6
phosphate (G6P) or glycolaldehyde (GA) [17]. Furthermore, the
addition of aminoguanidine (AG), a crosslink inhibitor, to the
glycating and crosslinking solutions prevented the increase in
crosslinking [17]. We now use this system of matrix modifica-
tion to evaluate the effects of nonenzymatic glycation and
crosslinking of matrix on the subsequent generation of matrix
proteins by cultured mesangial cells.
Evaluation of collagenase-sensizive proteins. Incorporation
of [3H] proline into collagenase-sensitive material consistently
ranged from 80 to 85% of PH] proline incorporated into total
protein (collagenase-sensitive plus collagenase-insensitive pro-
teins). In preliminary experiments we established that the PH]
proline incorporation into collagenase sensitive material repre-
sents collagen by the use of column chromatography followed
by hydroxyproline analysis of acid hydrolysates (Methods). The
column chromatography also confirmed that approximately
85% of PH] proline was incorporated into collagen. Analysis of
PH] proline and hydroxyproline by amino acid analysis of the
acid hydrolysates showed a ratio of about 1:5, consistent with
the expected ratio for collagen. Table 1 depicts the effect of
matrix modification on PH] proline incorporation into collage-
nase-sensitive protein produced by mesangial cells. Controls
were those where mesangial cells were plated onto mesangial
matrix treated with sodium phosphate buffer only, in the
absence of glycating solution. Mesangial cells plated onto
matrices glycated with glucose-6-phosphate (G6P) or
50 -—
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Fig. 1. Mesangial cells were plated onto control matrix (sodium phos-
phate; NAP), glycolaldehyde (GA), aminoguanidine (AG), or a combi-
nation of GA + AG modified matrices and [35S] incorporation into
proteins was determined. Results are means SEM of 4 experiments.
Asterisk indicates P < 0.05 as compared to control (NaP).
crosslinked by glycolaldehyde (GA) incorporated less [3H}
proline into collagenase-sensitive protein than mesangial cells
plated on control matrices (Table 1). Matrix modified with
aminoguanidine (AG) alone, an agent that blocks the matrix
modification by G6P and GA [35] had no effect on subsequent
collagen production by mesangial cells. Modifications of matrix
with G6P or GA in the presence of AG returned collagen
synthesis towards control values. Modification of matrix with
GA, which leads to a more marked degree of matrix modifica-
tion than G6P [361, also suppressed collagen synthesis to a
greater degree than that of mesangial cells plated on G6P-
modified matrix. [3H] proline incorporation into collagenase-
insensitive material was not significantly altered by the glycol-
aldehyde modified matrix (control: 17,330 4,660; GA: 15,710
4,310 CPM/well). Total protein synthesis, as evaluated by
24-hour 3H-serine labeling was not significantly affected in cells
grown on the modified matrices (control: 17,270 2,240; GA:
14,950 1,760; AG: 22,780 2,170; GA + AG: 16,670 1,530
CPM/well, N = 11).
Evaluation of 35S incorporation into proteins. Figure 1 de-
picts the generation of 35S labeled proteins (predominantly
proteoglycans) generated by mesangial cells over a 24 hour
period during culture on control and GA modified matrices.
Modification of the matrix with glycolaldehyde (GA) signifi-
cantly suppressed the production of 35S sulfated proteins by
MC. Modification of matrix with aminoguanidine alone had no
effect on the generation of 35S sulfated proteins by MC.
Co-modification of matrix by GA in the presence of ami-
noguanidine (AG) returned the [35S] incorporation into proteins
generated by MC towards control levels.
Experiments with cells grown on filters
The above experiments with mesangial cells plated on invitro
modifiedmatrices were designed to simulate effects of long term
elevations in glucose on mesangial matrix. As a complementary
experimental system, we also evaluated matrix generation by
MC maintained in standard or elevated glucose media on filters
for up to eight weeks without passaging. This should result in
glucose modification of the matrix deposited and accumulated
on the filters and should approximate the modified interactions
of mesangial cell and matrix that occur in patients with diabe-
tes. Total cellular protein, DNA, [3H] proline incorporation into
collagen, 35S-proteins and total glycosaminoglycan generation
by MC were evaluated after continuous culture of MC on the
filters for various periods of time (2 to 8 weeks).
Light and electronmicroscopy of the filters with mesangial
cells showed cells growing on and in the matrix that they had
deposited on the filters. No gross differences were apparent
between cells grown under control or elevated glucose condi-
tions (not shown).
Evaluation of total protein and DNA content of MC cultures.
Protein generation by mesangial cell cultures grown on filters
was evaluated by determination of the total protein content and
by protein synthesis via measurement of [3H] serine incorpora-
tion into TCA precipitable material. Table 2 depicts the total
protein content of the cultures, which increased over one to
eight weeks under both standard and elevated glucose culture
conditions, indicating continuous cell growth and matrix depo-
sition. No difference in protein content was seen between the
two culture conditions (elevated vs. standard glucose) at any
time point. This was supported by comparable [3H] serine
incorporation into both secreted (medium) and cell-associated
proteins from MC grown under standard or elevated glucose
conditions for four weeks (medium: 103,484 8795 vs. 94,639
4952 CPM/culture well, standard vs. elevated respectively;
cell-associated: 506,803 83,871 vs. 478,328 63,267 CPMI
filter, standard vs. elevated, respectively). Comparable cell
accumulation in standard and elevated glucose culture condi-
tions is also documented in Table 2 which shows the results of
cellular DNA per filter after 1, 2, 4 or 8 weeks of culture. Total
DNA increased to an equal extent under both conditions
throughout the eight week period, indicating continued cell
proliferation. Thus continuous culture of MC on filters with
elevated glucose medium did not change total protein or DNA
content after 1, 2, 4 or 8 weeks of culture as compared to
standard culture conditions, that is, high glucose in the medium
caused neither cell hypertrophy nor hyperplasia.
Evaluation of collagen generation. Collagen synthesis was
evaluated by [3H] proline incorporation into collagenase sensi-
tive proteins. In preliminary experiments we determined [3H]
proline uptake at 2, 6 and 12 hours by mesangial cells after
growth on filters for four weeks in standard or elevated glucose.
[3H] proline uptake by MC was comparable in elevated or
standard glucose media and, if anything, tended to be slightly
greater in the high glucose medium. In three experiments the
[3H] proline uptake in the elevated glucose group was 395,300
79,077 CPM/well after two hours, while in the standard glucose
group it was 294,846 33,503 CPM/well. At six hours, uptake
was 591,856 47,819 versus 423,626 42,473 CPM/well
(elevated vs. standard), and at 24 hours 812,637 114,633
versus 627,796 32,989 CPM/well (elevated vs. standard).
The use of [3H1 proline incorporation into collagenase-sensi-
tive protein as an index of collagen synthesis was substantiated
by several means. SDS-polyacrylamide gel-electrophoresis of
the [3H] proline labeled proteins secreted by MC (Fig. 2) shows
high molecular weight bands consistent with those expected for
procollagens in the presence of the crosslinking inhibitor beta-
aminopropionitrile in the incubation medium. These bands are
fully susceptible to digestion by collagenase. In Figure 2,
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Table 2. Protein and DNA content of MC grown on filters
Time in
culture
Standard glucose 200 mg/dl Elevated glucose 500 mg/dl
g prot/filter sg DNAIfilter sg prot/filter g DNA/filter
lweek 169±9(12) 96±7(10) 157±7(12) 84±9(10)
2 weeks 132 28 (9) 102 29 (9) 135 33 (9) 109 20 (9)
4 weeks 189 35(10) 113 25(10) 214 45(10) 125 28(10)
8 weeks 298 31(6) 173 17 (6) 326 12 (6) 187 15 (6)
A B C D
Columns A and C show the electrophoretic patterns for the
procollagens generated by MC grown in standard (STD) and
elevated (ELEY) glucose media, respectively, prior to treat-
ment with collagenase. Multiple bands are seen corresponding
to known molecular weights for the procollagens of types I and
IV. Columns B and D show that collagenase digested all of the
[3H] proline labeled collagen produced by the MC whether
grown in standard or elevated glucose medium. As a negative
and specificity control we used labeled albumin, which was not
digested by the collagenase (results not shown).
Figure 3 shows [3H] proline incorporation into collagenase-
sensitive protein (collagen) for mesangial cells grown in stan-
dard or elevated glucose for 2, 4 or 8 weeks. By two weeks,
cells grown in elevated glucose medium generated 15.2% less
collagen during the 24 hour labeling period than those grown in
Fig. 2. Autoradiograph of SDS-PAGE for
[3HJ pro/me incorporated into proteins by
mesangial cells is shown. MC were grown on
ifiters for 4 weeks with either standard
glucose (lanes A + B), or elevated glucose
media (lanes C + D), and then incubated for
24 hours with [3H1 proline. Aliquots of
ethanol-precipitates of the media were either
digested with collagenase (+) or left untreated
(—). Molecular weight standards are indicated
in K Dalton.
standard glucose medium. At four weeks, the decrease in
collagen synthesis by MC grown in elevated glucose was 24.3%
and by eight weeks 26.2% when compared to cells grown in
standard glucose media. Under either condition collagenase
sensitive protein corresponded to 83 to 88% of [3H] proline
incorporation into total protein. Collagenase insensitive counts
in the elevated glucose group were not statistically different
from controls (67,058 11,137 vs. 74,583 10,747 CPMlfilter,
elevated vs. standard glucose cultures after 4 weeks). We then
examined whether the decreased collagen production by MC
maintained long-term in high glucose media could be acutely
reversed by changing to standard glucose media during the
labeling period. Changing glucose concentrations in the media
from chronically elevated to standard for 24 hours did not
correct the decreased collagen production by MC that had been
Values represent means SE. Numbers in parentheses represent the number of determinations. Abbreviation is prot, protein. P = NS elevated
vs. standard at all time points.
STD ELEV
+ +
K
—200
—97
—69
—46
—30
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Time, weeks
Fig. 3. Prolonged culture of mesangial cells with media containing
elevated glucose concentrations (U, 500 mg/dl) decreased collagen
production as compared to culture with standard glucose (•, 200
mg/dl). Rat MC were continuously cultured on filters for the times
indicated. [3H] proline incorporation into collagenase-sensitive material
was then determined. Results are given as means SEM from 6 sets of
experiments each carried out in duplicate. * P < 0.001 vs. standard;
t P < 0.01 vs. standard.
maintained in elevated glucose media nor did a 24 hour change
from standard to elevated glucose media change collagen syn-
thesis (N = 6 for each group data not shown). This suggests that
decreased collagen production by MC maintained in high glu-
cose was not an acute effect of the high glucose medium.
All experiments on collagen synthesis were carried out in the
presence of ascorbic acid to enhance production [37]. In order
to assure that ascorbic acid does in fact enhance collagen
production under both standard and elevated glucose condi-
tions, the effect of ascorbic acid on the generation of collagen
types I and IV was evaluated and the results are depicted in
Figure 4. This figure represents [3H] proline incorporation into
material immunoprecipitated with antibodies raised against
either collagen I or collagen IV and run on a 7.5% SDS-
polyacrylamide gel followed by fluorography. Cells were grown
for four weeks in standard or elevated glucose and labeled with
[3H] proline for 24 hours in the presence or absence of ascorbic
acid. Ascorbic acid increased the amount of type I and IV
collagen generated in both the standard glucose and elevated
glucose conditions. It should be noted that for type IV collagen
immunoprecipitation four times more labeled starting material
was used. Thus in MC culture generation of type I collagen
exceeds that of type IV collagen by three- to fourfold, as
generally noted [17].
To further exclude the possibility that the decreased collagen
synthesis by MC maintained in high glucose media could be due
to glucose interference with ascorbic acid [38] we conducted
experiments in which MC were grown on filters for four weeks
in standard or elevated glucose media, labeled with [3H] proline
in the presence or absence of ascorbate, and evaluated for
collagenase-sensitive protein. Ascorbic acid increased collagen
production by cells grown in either standard or elevated glucose
medium. However, collagen production remained lower in
elevated glucose cultures as compared with control cultures,
irrespective of the presence or absence of ascorbic acid (N 6,
data not shown).
Evaluation of proteoglycans. We and others have previously
shown that cultured rat MC produce predominantly chon-
droitin-dermatan sulfate proteoglycans [39, 40]. In order to
evaluate production of these glycosaminoglycans, we deter-
mined ["S] incorporation into TCA precipitable and guanidine-
extractable proteins. Table 3 shows [35S] incorporation into
protein generated by MC grown in media with either standard
or elevated glucose concentrations for four weeks. Cells grown
in high glucose consistently incorporated 28% less ["S] into
proteoglycans extractable from cells and extracellular matrix
than MC grown in standard glucose. Incorporation of ["SI into
TCA precipitable proteoglycans secreted into the medium was
also 20% decreased in MC maintained under the elevated
glucose as compared to standard glucose culture conditions.
The ratio of [35S] proteins found in the media as compared to
the cell and matrix layer was independent of whether MC had
been cultured in standard or elevated glucose media (4.0 vs. 4.1;
standard vs. elevated glucose, respectively). ["Si incorporation
evaluates the sulfation of glycosaminoglycan chains, but does
not necessarily reflect their total amount. We therefore also
determined the total amount of glycosaminoglycans present in
the cells and matrix present on the filters by the uronic acid
method [261. Table 4 shows the total amount of glycosamino-
glycans present after four weeks of MC culture in standard or
elevated glucose media. Total glycosaminoglycan content of
cell layer and extracellular matrix accumulated after four weeks
of culture was the same regardless of the glucose concentration
in the culture media. Thus, in spite of lower degrees of ["SI
sulfation of proteoglycans generated by MC maintained in high
glucose medium, the total glycosaminoglycan content was
unchanged by the different glucose culture conditions. This was
confirmed by running proteoglycans generated by cells grown
long term in standard or elevated glucose on a DEAE anion
exchange column [41]. The proteoglycans produced by MC
maintained in high glucose eluted from the column at a lower
[NaC1] concentration (0.42 M vs. 0.52 elevated vs. standard),
indicating a reduction in negative charges (Fig. 5). These
findings are consistent with a lesser degree of sulfation of
proteoglycans generated by MC grown in high glucose, as
previously reported by us in short term cultures [14].
Northern blot analysis. A representative Northern blot de-
picting levels of mRNA for collagen type I (alpha-2 chain
procollagen I), collagen type IV (alpha 1 chain), TGF-13 and
biglycan, is shown in Figure 6. No difference in mRNA levels
for any of these parameters was found between control and high
glucose cultures at either time point (2 or 4 weeks). The
densitometry readings for mRNA for collagen I and IV, TGF-f3
and biglycan normalized for GAPDH and 18S RNA are shown
in Table 5. These values represent three series of experiments
at the two week time point and four series of experiments at the
four week time point. No difference in mRNA levels was found
between the control (regular) and high glucose cultures in any of
the parameters evaluated, either at two or four weeks of
growth. Thus maintaining MC in continuous culture with ele-
vated glucose in the medium results in significantly decreased
collagen production but essentially unchanged mRNA levels for
collagen I and IV, as well as biglycan and TGF-/3.
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Fig. 4. Autoradiograph of SDS-PAGE of[3H] proline incorporated into proteins immunoprecipitated with antibody against collagen type IV (A)
or collagen type I (B). Mesangial cells were grown on filters for 4 weeks with either standard (STD) or elevated (ELEV) glucose media and then
incubated for 24 hours with the same media containing [3H] proline with (+) or without (—) ascorbic acid (50 sg/ml). The media were then
immunoprecipitated with antibody for collagen type IV or collagen type I and the precipitate separated on SDS-PAGE followed by
autoradiography. Molecular weight standards are indicated in K Dalton.
CPMlculture dish
Medium Cell + ECM
Standard glucose 128,215 14,550 32,233 457
200 mg/dl
Elevated glucose 92,485 6,420a 22,714 88&
500 mgldl
MC were grown for 4 weeks on filters in either standard glucose
medium (200 mg/dl) or elevated glucose medium (500 mg/dl). Cells were
then labeled with 35S-Na2SO4 for 24 hr and proteoglycans/glycosami-
noglycans extracted. All values represent the mean of 6 determinations
SE. Abbreviation is ECM, extracellular matrix.
P < 0.05 elevated vs. standard
>(
0>
C)0
a)0
0.
C,)
nmollwell
Standard glucose 200 mgldl Elevated glucose 500 mg/dl
20.86 2.89 23.58 2.55
(6) (10)
Mesangial cells were grown for four weeks on filters in either
standard or elevated glucose media. Total glycosaminoglycan content
of mesangial cells and their matrix was then determined on guanidine
extracts by the uronic acid method. Numbers in parentheses represent
the number of determinations. Abbreviation is ECM, extracellular
matrix.
P = NS standard vs. elevated
Fig. 5. Mesangial cells were continuously cultured for four weeks on
filters with media containing either standard (x—x; 200 mg/dl) or
elevated (• •, 500 mg/dl) glucose concentrations. [35S1 incorpora-
tion into proteoglycans was then evaluated after the labeled material
was extracted from cells and matrix with guanidine, and eluted from a
DEAE-sepharose anion exchange column with a linear NaCI gradient
(0.15 to 1.15 M). The earlier elution of [35S1 labeled proteoglycans from
MC grown in elevated glucose medium indicates a lower negative
charge than those isolated from MC grown in standard glucose.
STD.
glucose
Elev.
glucose
STD.
glucose
Elev.
glucose
Table 3. li35S] incorporation into guanidine extractable protein 30
25
20
15
10
5
0
Table 4. Total glycosaminoglycan content of MC and ECM
16 20 24 28 32 36 40 44
Fraction number
Discussion
Our experiments were designed to examine the effects of
chronic elevation in glucose and the resulting glucose-modifi-
cations of matrix on collagen and proteoglycan production by
cultured mesangial cells. Contrary to the increase in matrix
production reported after short-term (days) culture of renal
cells in elevated glucose media, we observed that long-term
continuous (that is, weeks without passage) maintenance of MC
on their own matrix in high glucose media results in decreased
collagen production. Similarly, plating mesangial cells on ma-
trix modified with glucose-6-phosphate or glycolaldehyde, to
mimic nonenzymatic glycation and crosslinking, also decreases
collagen production by MC. Our results raise the possibility
that matrix accumulation in diabetes mellitus may be a dynamic
process and not solely explicable by increased matrix produc-
tion.
The extracellular matrix can be considered as partially re-
flecting the metabolic history of the cell [42]. This paradigm can
be applied to diabetes mellitus (DM) where the elevated glucose
may influence both the biology of cells and their extracellular
matrix. A major alteration of matrix in DM may be related to
nonenzymatic glycation of matrix components [11]. Elevated
glucose levels result in nonenzymatic glycation of proteins both
•
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Table 5. Comparison of mRNA levels in mesangial cells grown on
filters in standard or elevated glucose medium for 2 or 4 weeks
mRNA
levels
2 Weeks 97o Standard 4 Weeks 97o Standard
A B A B
Collagen! 128 16 114 31 95 22 106 29
Collagen IV 160 8 141 31 Ill 23 121 21
TGF-13 98 8 79 12 94 13 83 8
Biglycan 114 11 100 24 115 23 142 46
Rat MC were continuously grown on filters in either standard (200
mg/dl) or elevated glucose (500 mg/dl) medium. After 2 and 4 weeks
RNA was isolated and mRNA levels determined by Northern blot
analysis for collagen!, collagen IV, TGF-/3, biglycan, GAPDH and l8S
ribosomal RNA. Levels of mRNA were determined by Laser scan
densitometry of the autoradiographs. Values represent elevated glucose
mRNA levels shown as a percent of standard glucose mRNA levels.
Values are corrected for potential loading variations of RNA by
factoring mRNA levels for either GAPDH (A) or 18S ribosomal RNA
(B). Results are means SEM from 3 separate series of experiments at
2 weeks, and 4 series of experiments at 4 weeks.
Biglycan
GAPDH
1 8S-rRNA
—2.6
—1.4
—1.8
Reg. high Reg. high
2 weeks 4 weeks
Fig. 6. Rat MC were grown on filters with either regular (200 mg/dl) or
high (500 mg/dl) glucose media for two or four weeks prior to extraction
of total RNA. Northern blot analysis was performed with 10 sg of total
RNA per lane and hybridized under high stringency conditions for the
pro-alpha 2 chain of type I collagen, the alpha-i chain of collagen IV,
TGF-31, biglycan, GAPDH, and 18S ribosomal RNA. No difference
between the regular or high glucose cultures was found in any param-
eter evaluated.
in vivo and in vitro. In proteins with slow turn-over, this
eventually results in the formation of advanced glycation end
products (AGE). This process can also lead to crosslinking of
proteins [11]. AGE occur in diabetes and together with abnor-
mal crosslinking of matrix components are thought to contrib-
ute to the expansion of extracellular matrix in DM [7]. We
developed an in vitro system designed to mimic advanced
glycation and crosslinking of matrix in DM. The system con-
sists of matrix generated by cultured MC which is then chem-
ically modified with either glucose-6-phosphate (G6P) or the
reactive aldehyde, glycolaldehyde (GA). GA will cause forma-
tion of AGE-like modification and crosslinking, similar to that
thought to occur with long-standing glycation [36]. Formation
of the AGE can be prevented by addition of aminoguanidine.
Using this system we had previously shown that proliferation is
decreased when MC are plated on G6P or GA-modified matri-
ces; effects reversed by co-treatment with AG [17]. We now
explored the effect of these matrix modifications on the subse-
quent generation of matrix proteins by MC.
Modification of matrix by G6P decreased collagen production
by MC by 16% and modification by GA by 43%. These effects
were preventable when aminoguanidine was included during
matrix modification. Aminoguanidine prevents AGE formation,
as reflected in our system of mesangial matrix modification [17].
Comparable results were obtained for [35S] incorporation into
proteoglycans, which was also decreased in MC plated on GA
modified matrix. The greater inhibition of collagen synthesis by
MC plated on GA- than G6P-modified matrices also resembles
the greater degree of inhibition of MC proliferation by GA
modification previously reported by us [17]. It is of interest in
this context that GA results in a considerably higher degree of
matrix modification than G6P [36]. Together with the preven-
tion of these phenomena by AG, these observations indicate
that AGE-like modification of matrix components affects be-
havior of cells. The decrease in generation of matrix compo-
nents by MC plated on modified matrices may be part of a
general alteration in cell behavior. We previously reported
decreased cell proliferation on modified matrices [17], and
protein synthesis in this study (evaluated by [3H] serine incor-
poration) also tended to be reduced, though not reaching
statistical significance.
The chemical modification of matrix represents a simple
experimental system that allows evaluation of the influence of
isolated matrix modifications on MC biology. However, it may
be perceived as extreme and artificial. We therefore developed
an additional culture system which allows continuous mainte-
nance of MC grown on filters in culture wells. This system
avoids passaging MC every two weeks, which each time results
in the loss of extracellular matrix previously deposited by the
cells. With maintenance of cells on filters, any modification of
matrix and or MC biology that might occur in continuous
culture will be preserved. In fact, examination of MC grown on
Coil. I
Coil. IV
TGF-
—5.7
—4.7
—6.0
—2.4
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filters by light or scanning electron microscopy showed mesan-
gial cells embedded in their matrix anchored to the filter
material. Cellular growth and proliferation continued for at least
up to eight weeks of continuous culture on filters in either
standard or elevated glucose media as judged by total protein
and DNA content. No differences in total protein or DNA
content were observed between MC cultured in standard and
elevated glucose media. These results show that under our
culture conditions (that is, with 8% Nu-Serum) raising glucose
from 200 mgldl to 500 mgldl has no adverse effects on MC
growth. The high glucose media resulted in a progressive
decline in collagen synthesis from two to eight weeks of culture
as compared to standard glucose conditions. These effects were
not reversible by acutely changing glucose concentrations over
24 hours. They could also not be explained by elevated glucose
interfering with [3H] proline uptake or with the effects of
ascorbic acid on collagen synthesis [43]. The latter control was
performed as glucose has been reported to interfere with
ascorbic acid uptake by cells [43] and since changes in ascorbic
acid metabolism occur in DM [43, 44]. At least two-thirds of the
collagen generated was of type I, as judged by immunoprecip-
itation and Northern blot analysis. Predominance of type I
collagen production by cultured MC is consistent with reports
by others [45] and our previous report [17]. This is in contrast to
the predominance of type IV collagen seen in vivo in the
mesangial matrix. The suppressed collagen synthesis seen in
these studies conducted on filters was not accompanied by a
reduction in total protein synthesis since 3H serine incorpora-
tion was the same in the two glucose conditions at four weeks
of growth.
The decrease in collagen synthesis by MC maintained in high
glucose media was associated with essentially unchanged
mRNA levels for collagen I and IV. The reason for the
discrepancy between lower collagen synthesis and unchanged
levels of mRNA for collagen remain to be examined. Given the
range of change (15 to 26%) in collagen production in the
elevated glucose condition, small changes in mRNA may not be
easily detectable. In addition, this type of dissociation between
mRNA levels and protein product is not an uncommon obser-
vation in studies of matrix generation. It is of interest that
mRNA levels for TGF-f31 were also comparable in MC main-
tained under the chronic high glucose conditions as compared
to standard glucose. TGF-f3 is a cytokine with major effects on
matrix remodeling. It stimulates synthesis of matrix compo-
nents and inhibits matrix degradation [46]. Enhanced TGF-p
generation has therefore been implicated as a contributor to
glomerular sclerosis in experimental models of glomerulone-
phritis [47]. Recently it has been shown that acute (48 hr)
elevations of glucose in culture media can enhance mRNA
levels for TGF-f3 in proximal tubular cell culture [13]. However,
this elevation did not persist beyond 72 hours of culture in high
glucose media [13]. This finding would be consistent with the
unchanged levels of mRNA for TGF-/3 in our experiments with
prolonged culture in high glucose.
It is tempting to speculate that common factors might con-
tribute to the decreased collagen production by MC plated on
glycated matrix or maintained long-term in high glucose media,
a maneuver that should also lead to progressive nonenzymatic
glycation of the matrix deposited by MC. This glycation would,
however, be expected to be of a lesser extent than that
produced by chemical modification with G6P or GA. How such
modification would in turn influence collagen synthesis by MC
remains to be evaluated, but could involve altered interactions
between cells, growth factors and modified matrix. Whatever
the explanation may be, our results indicate that high glucose
culture conditions do not lead to relentless stimulation of
collagen production. Rather, it appears that stimulation of
collagen synthesis by high glucose is a self-limited phenomenon
with long-term elevation of glucose even resulting in decreased
collagen production. These results indicate a much more dy-
namic effect of glucose on matrix production, as was also found
in experimental models of DM. For example it has been
reported that mRNA levels for collagen isolated from kidneys
of animals with short-term (weeks) experimental DM are ele-
vated [48]. However, after months of DM, renal collagen
mRNA levels return to normal [49]. Whether and how this
might relate to our observation will require further studies.
Irrespective of these potential relationships, it can be stated
that elevated glucose concentrations may influence the genera-
tion of different matrix components differently. For example,
collagen synthesis is decreased by high glucose media but total
glycosaminoglycan accumulation is not. However, the degree
of [35S] sulfation of glycosaminoglycans produced by MC plated
on glycated matrix or maintained in high glucose medium was
consistently less than that from MC grown under control
conditions. These results are consistent with our previous
findings of decreased sulfation and hence charge of chondroitin-
dermatan sulfate proteoglycans generated by MC cultured in
elevated glucose media [14]. Decreased degrees of charge and
sulfation have been reported for heparan sulfate proteoglycans
isolated from diabetic glomeruli [50—52], but so far only minor
changes in mesangial chondroitin-dermatan sulfates have been
noted [53—55]. Differences of sulfation and charge of the gly-
cosaminoglycans may be of considerable importance for the
behavior of the extracellular matrix in DM. Both proteoglycan-
fibronectin and proteoglycan-collagen interactions are partially
mediated by the charged side chains of the proteoglycans [56,
57]. Changes in sulfated side chains could alter the interaction
of matrix components, resulting in different assembly and
function of the matrix. Furthermore, they might influence
interactions of growth factors and matrix and of cells and
matrix, factors that may be important in the development of
diabetic glomerulopathy.
In summary, our data illustrate that plating MC on glycated
matrix or maintaining MC in high glucose media for two to eight
weeks results in decreased collagen synthesis and decreased
sulfation of proteoglycans. These results indicate that elevated
glucose may have dynamic effects on matrix generation by
cultured MC. While short-term culture (days) can enhance
collagen synthesis, long-term (weeks) culture may depress
further synthesis. Extrapolating these in vitro results to the in
vivo situation, we propose that the matrix expansion of diabetic
glomerulopathy may not be solely explicable by enhanced
collagen deposition, but may also require decreased collagen
break-down, the latter possibly related to advanced nonenzy-
matic glycation of matrix components.
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